Kidney & Urology Foundation of America
Kidney & Urology Foundation of America
SAVE THE DATE:
Support Walk the Walk
New York Walk the Walk

October 31, 2010 - Central Park
REGISTER ONLINE NOW!
join us on Facebook
Join KUFA today
and become an essential part of the fight to save and improve lives. There are no fees for patients, family and friends to get connected!

 

Patient Resources


Therapeutic Areas: Oncology | Family Medicine

Adenocarcinoma Clinical Trials


A listing of Adenocarcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Huntsville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Huntsville : Clearview Cancer Institute

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Arizona

Chandler :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Chandler :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Flagstaff : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Glendale :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Hot Springs :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Jonesboro :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Phoenix :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Prescott Valley : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Scottsdale : Scottsdale Healthcare

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Scottsdale :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Scottsdale : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Scottsdale : Translational Genomics Research Institute (TGen)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Scottsdale : Mayo Clinic Arizona (Site 229)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Scottsdale : Scottsdale Healthcare Research Institute Updated

A clinical trial to evaluate treatments using MMB, Capecitabine and Oxaliplatin for patients with Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma

Scottsdale : Mayo Clinic Arizona

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Scottsdale :

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Tucson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Tucson : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tucson : Arizona Cancer Center at University Medical Center North

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Tucson :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Arkansas

Fayetteville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Hot Springs : Genesis Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

California

Anaheim : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bakersfield :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Corona : Comprehensive Cancer Care Medical Group, Inc.

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Corona :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Duarte : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Duarte : City of Hope, Site #009

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Duarte : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Duarte : City of Hope

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

El Cajon :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Fountain Valley : Compassionate Care Research Group, Inc.

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Fullerton :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Gilroy :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Hollywood : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

La Jolla : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

La Jolla :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

La Jolla : Moores Cancer Center University of California, San Diego, Site #099

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

La Jolla : UC San Diego Moores Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

La Mesa :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Loma Linda : Loma Linda University

A clinical research study of PEG-BCT-100 for the treatment of Hepatocellular Carcinoma, Renal Cell Carcinoma, Melanoma or Prostate Adenocarcinoma

Long Beach :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Los Angeles : UCLA Department of Medicine

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Los Angeles : Cedars Sinai Medical Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Los Angeles : USC Norris Comprehensive Cancer Center

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Los Angeles : Cedars-Sinai Medical Center Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Los Angeles : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Los Angeles : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Los Angeles : University of Southern California/Norris Cancer Center

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Modesto :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Northridge :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Oceanside :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Orange : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Oxnard : Ventura County Hematology-Oncology Specialists

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Pasadena : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Redondo Beach : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Redondo Beach :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Riverside : Compassionate Cancer Care Medical Group, Inc.

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Sacramento : University of California Davis

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sacramento : UC Davis Comprehensive Cancer Center

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

Sacramento : UC Davis Comprehensive Cancer Center

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Sacramento : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

San Diego : Kaiser Permanente, Site #208

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

San Diego :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer, Adenocarcinoma or Pancreatic Neoplasms

San Francisco : University of California San Francisco

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

San Francisco : UCSF - Mount Zion

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

San Francisco :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

San Jose : Global Cancer Research Institute

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

San Luis Obispo :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Santa Maria :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Santa Monica : University of California, Los Angeles Medical Center (UCLA)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Santa Monica :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Whittier : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Whittier : Innovative Clinical Research Institute

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Whittier :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Colorado

Aurora : University of Colorado Cancer Center

A clinical research study of Ponatinib

Aurora :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Aurora :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Aurora : University of Colorado Cancer Center

A clinical trial to evaluate treatments for patients with Metastatic Pancreatic Cancer

Aurora : Anschutz Inpatient Pavilion

A clinical trial to evaluate treatments for patients with Metastatic Pancreatic Cancer

Aurora : University of Colorado Denver, CTO (CTRC)

A clinical trial to evaluate treatments for patients with Metastatic Pancreatic Cancer

Aurora : Drug Shipment: Anschutz Cancer Pavilion

A clinical trial to evaluate treatments for patients with Metastatic Pancreatic Cancer

Aurora : University of Colorado Cancer Center, Site #015

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Aurora : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Aurora : University of Colorado

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Aurora : University of Colorado Anschutz Medical Campus

Patients are needed to participate in a clinical research study of IMMU-132

Denver : Rocky Mountain Cancer Centers

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Denver :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Denver :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Edwards : The Shaw Regional Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Grand Junction :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Lone Tree :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Pueblo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Connecticut

Hartford : Saint Francis Hospital and Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

New Haven : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

New Haven : Yale Cancer Center (Site 033)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

New Haven : Yale University

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

New Haven : Research Site

Patients are needed to participate in a clinical research study of Olaparib and Placebo to evaluate Germline BRCA1/2 Mutations and or Metastatic Adenocarcinoma of the Pancreas

Southington :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Trumbull :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Delaware

Newark : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Newark : Christina Care Health System

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Newark : Helen F. Graham Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Newark :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

District of Columbia

Washington : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Florida

Boca Raton : Lynn Cancer Institute/Boca Raton Regional Hospital

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Boca Raton : Lynn Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boca Raton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boca Raton :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Deerfield Beach : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Fort Myers :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Fort Myers : Florida Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gainesville : University of Florida

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Jacksonville : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Jacksonville : Baptist Cancer Institute

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lake Worth : Cancer Center of South Florida, Site #204

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Miami :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Miami : UM Sylvester Comprehensive Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Miami : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Miami :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Miami Beach : Mount Sinai Medical Center CCOP

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

New Orleans : Ochsner Health System/The Gayle and Tom Benson Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Ocala : Ocala Oncology Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Ocala :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Orange Park :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Orlando : Florida Hospital

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Orlando : Florida Hospital Cancer Institute Memorial System

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Orlando : MD Anderson Cancer Center Orlando

Patients are needed to participate in a clinical research study of IMMU-132

Pembroke Pines : Memorial Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Pensacola : Sacred Heart Medical Oncology Group - Davis Highway

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Pensacola : Sacred Heart Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Sarasota : Florida Cancer Specialists / Sarah Cannon Research Institute

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

St. Petersburg :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

St. Petersburg :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

St. Petersburg :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

St. Petersburg : Florida Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tampa :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Tampa :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A clinical trial seeking patients for a research study for the treatment of Prostate Cancer

Tampa : H. Lee Moffitt Cancer Center (Site 017)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Tampa : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tampa : Moffitt Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Georgia

Savannah : Memorial University Medical Center

RTOG 1010: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

Athens :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Atlanta :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Atlanta : Piedmont Hospital Research Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Atlanta : Winship Cancer Institute of Emory University, Site #058

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Atlanta : Northside Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Atlanta : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Atlanta : Emory University Winship Cancer Institute

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Atlanta :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Augusta : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Augusta : Georgia Regents University

Patients are needed to participate in a clinical research study of Nab-Paclitaxel, Gemcitabine and Indoximod to evaluate Metastatic Pancreatic Adenocarcinoma or Metastatic Pancreatic Cancer

Marietta : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Marietta :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Maron :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Rome :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Illinois

Arlington Heights : Illinois Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Arlington Heights :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Chicago : University of Chicago Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer, Adenocarcinoma or Pancreatic Neoplasms

Chicago : University of Chicago (Site 001)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Chicago : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Chicago : University of Chicago

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chicago : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Decatur : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Effingham : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Evanston : Northshore University Healthsystem Research Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Harvey :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Niles : Oncology Specialists, S.C.

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Peoria : Illinois Cancer Care - Peoria

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Quincy : Quincy Medical Group - Clinic

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Indiana

Goshen : Indiana University Health Goshen Center for Cancer Care Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Goshen : IU Health Goshen Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Goshen :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Indianapolis :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Indianapolis : IU Simon Cancer Center

Patients are needed to participate in a clinical research study evaluating porfimer sodium, endoscopic ultrasonography, photodynamic therapy and gemcitabine hydrochloride for the treatment of Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas or Stage III Pancreatic Cancer

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Indianapolis : Investigative Clinical Research of Indiana, LLC

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Lafayette :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Mishawaka : Michiana Hematology Oncology PC-Mishawaka

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Terre Haute : RHHP/Hope Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Westville : Michiana Hematology Oncology-PC Westville

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Iowa

Ames : McFarland Clinic Oncology

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Bettendorf : Hematology Oncology Associates - Quad Cities

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Davenport : Genesis Medical Center - East Campus

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Iowa City : VA Medical Center - University of Iowa

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Iowa City : University of Iowa Hospitals and Clinics

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Kansas

Topeka :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Wichita : Cancer Center of Kansas

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Kentucky

Ashland :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Louisville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Louisville : CBC Group Consulting in Blood Disorders and Cancer, PSC

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Paducah : Western Kentucky Hematology and Oncology Group

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Louisiana

Marrero : West Jefferson Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Marrero : Crescent City Research Consortium

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Marrero :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

New Orleans :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

New Orleans : Ochsner Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Maine

Augusta : Harold Alfond Center for Cancer Care

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Bangor : Eastern Maine Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Scarborough :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Maryland

Annapolis :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Baltimore :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A clinical trial to evaluate treatments using CRS-207, GVAX, nivolumab and CY for patients with Previously Treated Metastatic Adenocarcinoma of the Pancreas

Baltimore : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 1/Phase 2 clinical study for patients with Resectable Pancreatic Adenocarcinoma

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Bethesda : Center for Cancer and Blood Disorders

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Bethesda :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Easton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Frederick : Frederick Memorial Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Rockville :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Massachusetts

Boston :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Boston :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Boston : Dana Farber Cancer Institute

A clinical trial seeking patients for a research study of LY2875358 and Ramucirumab

Boston : Dana Farber Cancer Institute Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Boston : Beth Israel Deaconess Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Dana Farber Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Massachusetts General Hospital Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boston : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating Enzalutamide, Abiraterone Acetate, Prednisone and Leuprolide Acetate for the treatment of Prostate Adenocarcinoma, Prostate Cancer or High Risk Prostate Cancer

Boston : Beth Israel Deaconess Medical Center

Patients are needed to participate in a clinical research study evaluating Enzalutamide, Abiraterone Acetate, Prednisone and Leuprolide Acetate for the treatment of Prostate Adenocarcinoma, Prostate Cancer or High Risk Prostate Cancer

Boston : Massachusettes General Hospital

Patients are needed to participate in a clinical research study of IMMU-132

Worcester :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Michigan

Ann Arbor : University of Michigan

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Ann Arbor : University of Michigan

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Ann Arbor : Saint Joseph Mercy Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Ann Arbor :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Detroit : Henry Ford Health System

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Detroit : Karmanos Cancer Institute

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Detroit : Wayne State University/Karmanos Cancer Institute Wayne St

A Phase 1 clinical study for patients using LGK974

Detroit : Karmanos Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Detroit : Wayne State University/Karmanos Cancer Institute

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Detroit : Henry Ford Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Detroit :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Escanaba : Green Bay Oncology - Escanaba

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Farming Hills :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Iron Mountain : Green Bay Oncology - Iron Mountain

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Lansing : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Livonia : Saint Mary Mercy Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Saginaw : Saint Mary's of Michigan

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Minnesota

Coon Rapids : Mercy Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Duluth : Essentia Health Duluth Clinic CCOP

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Rochester : Mayo Clinic

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Rochester : Mayo Clinic (Site 044)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Rochester : Mayo Clinic

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

Shakopee : Saint Francis Regional Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Louis Park :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

St. Louis Park : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

St. Louis Park : Park Nicollet Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Stillwater : Lakeview Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Woodbury : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Woodbury :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Missouri

Bridgeton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cape Girardeau : Saint Francis Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Chesterfield : Saint Luke's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Columbia : University of Missouri - Ellis Fischel

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Jefferson City :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Kansas City :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Springfield : Mercy Hospital - Springfield

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Louis :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

St. Louis : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

St. Louis : Missouri Baptist Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Louis : Washington University School of Medicine

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Louis : Washington University in St. Louis

Patients are needed to participate in a clinical research study of Nab-Paclitaxel, Gemcitabine and Indoximod to evaluate Metastatic Pancreatic Adenocarcinoma or Metastatic Pancreatic Cancer

St. Louis :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Montana

Billings : Saint Vincent Healthcare

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Bozeman : Bozeman Deaconess Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Nebraska

Omaha :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Omaha : Nebraska Cancer Specialists, Methodist Estabrook Cancer Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Omaha : UNMC Eppley Cancer Center at the University of Nebraska Medical Center

A clinical trial seeking patients for a research study of ADH-1, cisplatin, gemcitabine hydrochloride and laboratory biomarker analysis

Omaha : Methodist Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Omaha : Nebraska Methodist Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Omaha :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Nevada

Henderson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Las Vegas :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Las Vegas : HealthCare Partners Medical Group Oncology/Hematology-Tenaya

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Las Vegas : HealthCare Partners Medical Group Oncology/Hematology-San Martin

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Las Vegas :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

New Hampshire

Concord : New Hampshire Oncology - Hematology PA

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Dover : Wentworth Douglass Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Hooksett : New Hampshire Oncology Hematology Associates

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Laconia : LRGHealthcare-Lakes Region General Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Lebanon : Dartmouth-Hitchcock Norris Cotton Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

New Jersey

Basking Ridge : Memoral Sloan Kettering Cancer Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Basking Ridge : Memorial Sloan-Kettering Cancer Center at Basking Ridge

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Basking Ridge : Memoral Sloan Kettering Cancer Center

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

Basking Ridge : Memoral Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Esophageal Adenocarcinoma

Cherry Hill : Regional Cancer Care Associates/Cherry Hill Division, LLC.

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

East Brunswick : Regional Cancer Care Associates

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Livingston : Saint Barnabas Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Morristown : Regional Cancer Care Associates/ Carol G. Simon Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Somerville : Regional Cancer Care Associates/ Somerset Division

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Voorhees :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

New Mexico

Albuquerque : University of New Mexico

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Farmington :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Las Cruces : Memorial Medical Center-Las Cruces

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Santa Fe : Christus Saint Vincent Regional Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

New York

Binghamton :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Birmingham :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Bronx : Montefiore Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Bronx : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Bronx :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Brooklyn : Maimonides Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Buffalo : Roswell Park Cancer Institute

A clinical trial to evaluate treatments using vorinostat, temsirolimus, laboratory biomarker analysis and positron emission tomography/computed tomography for patients

Buffalo : Roswell Park Cancer Institute

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Commack : Memorial Sloan-Kettering Cancer Center at Commack

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Commack : Memorial Sloan Kettering Cancer Center @ Suffolk

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

Fresh Meadows :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Hudson :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Hudson :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Jamaica : Queens Cancer Center of Queens Hospital

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Johnson City : Broome Oncology, LLC

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lake Success : Clinical Research Alliance

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lake Success : NYU Langone Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New Hyde Park : Long Island Jewish Medical Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New York : Memorial Sloan Kettering Cancer Center

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma or Distal Esophageal Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center 1275 York Avenue

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New York : New York University

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Small Cell Prostate Cancer, Neuroendocrine Prostate Cancer or Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers

New York : Memorial Sloan Kettering Cancer Center

A clinical trial seeking patients for a research study of LY2875358 and Ramucirumab

New York : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

New York : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using degarelix injection and androgen deprivation therapy for patients with Prostate Cancer or Prostatic Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

New York : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

New York : Memorial Sloan Kettering Cancer Center

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

New York : Memorial Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Esophageal Adenocarcinoma

New York : Columbia University Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New York : Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine

Patients are needed to participate in a clinical research study evaluating CDX-1127

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

New York : Weill Cornell/New York Presbyterian Hospital

Patients are needed to participate in a clinical research study of IMMU-132

New York :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Nyack :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Rochester : University of Rochester

A clinical trial to evaluate treatments for patients with Metastatic Pancreatic Cancer

Rochester : University of Rochester Investigational Drug Pharmacy

A clinical trial to evaluate treatments for patients with Metastatic Pancreatic Cancer

Rochester : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Rochester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Rochester : University of Rochester Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rockville Centre : Memorial Sloan-Kettering at Mercy Medical Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Rockville Centre : Memorial Sloan-Kettering Cancer Center at Mercy Medical Center

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Rockville Centre : Memorial Sloan Kettering at Mercy Medical Center

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

Sleepy Hollow : Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Sleepy Hollow : Memorial Sloan-Kettering Cancer Center Sleepy Hollow

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Sleepy Hollow : Memoral Sloan Kettering Cancer Center at Phelps

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

North Carolina

Asheboro : Randolph Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Chapel Hill : Lineberger Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Chapel Hill : UNC Health Care; N.C. Cancer Hospital Infusion/Inpatient Pharmacy (CHIP) (Site 032)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Chapel Hill : University of North Carolina

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Chapel Hill : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Charlotte : Carolinas Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Charlotte : Novant Health Presbyterian Medical Center, Site #205

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Charlotte : Novant Health Presbyterian Medical Center

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Charlotte : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Charlotte : Levine Cancer Institute

Patients are needed to participate in a clinical research study to evaluate Lung Cancer, NSCLC or NSCLC Adenocarcinoma

Durham : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Durham :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Greensboro : Core Health Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Reidsville : Annie Penn Memorial Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Washington : Marion L. Shepard Cancer Center at Beaufort County Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Winston-Salem : Novant Health Oncology Specialists/Forsyth Memorial Hospital

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Winston-Salem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Winston-Salem : Wake Forest Baptist Health

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Winston-Salem : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Winston-Salem :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

North Dakota

Bismarck : Sanford Bismarck Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Fargo : Sanford Clinic North-Fargo

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Fargo : Sanford Medical Center-Fargo

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Ohio

Canton : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Canton :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Canton :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Canton : Gabrail Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Cincinnati :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Cincinnati :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Cincinnati :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Cincinnati : Oncology Hematology Care Inc.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Cleveland : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Cleveland : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Cleveland : Cleveland Clinic Foundation

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Cleveland : Case Western Reserve University

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Cleveland : Cleveland Clinic Foundation

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

A clinical trial to evaluate treatments using panitumumab, irinotecan hydrochloride, fluorouracil and leucovorin calcium for patients

Columbus : Ohio State University Comprehensive Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Columbus : Ohio State University Medical Center

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Columbus :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Middletown :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Toledo :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Oklahoma

Lawton : Cancer Centers of Southwest Oklahoma

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lawton : Cancer Centers of Southwest Oklahoma, LLC - Lawton

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Oklahoma City : Oklahoma University

A clinical research study of MORAb-066

Oklahoma City : University of Oklahoma Peggy and Charles Stephenson Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Oklahoma City : University of Oklahoma Health Sciences Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Tulsa : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Oregon

Corvallis : Good Samaritan Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Eugene :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Portland :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Portland :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Portland : Oregon Health and Sciences University

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Portland : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Portland : Providence Health & Services

Patients are needed to participate in a clinical research study of DRibble Vaccine for Prostate Cancer Patients

Portland : Kaiser Permanente Health Care - Portland

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Portland :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Pennsylvania

Gettysburg : Adams Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Hershey : Penn State/Milton S Hershey Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Philadelphia : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Philadelphia : University of Pennsylvania

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Philadelphia : University of Pennsylvania

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Philadelphia : Thomas Jefferson University

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study of Alisertib, Abiraterone acetate and Prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study of Enzalutamide, Goserelin acetate, Leuprolide acetate and Radiation therapy

Pittsburgh : University of Pittsburgh Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Pittsburgh : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pittsburgh : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

PIttsburgh : Allegheny Singer Research Institute- West Penn

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Pittsburgh : University of Pittsburgh Medical Center

Patients are needed to participate in a clinical research study of Nab-Paclitaxel, Gemcitabine and Indoximod to evaluate Metastatic Pancreatic Adenocarcinoma or Metastatic Pancreatic Cancer

York : WellSpan Health-York Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

South Carolina

Charleston :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Charleston : Medical Universtiy of South Carolina (MUSC)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Charleston : Medical University of South Carolina

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Charleston :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Spartanburg :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

South Dakota

Sioux Falls : Sanford Cancer Center Oncology Clinic

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Watertown : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tennessee

Chattanooga :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Chattanooga : Tennessee Oncology - Chattanooga

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chattanooga : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Chattanooga : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Germantown : The Jones Clinic

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Knoxville : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Knoxville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Knoxville : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Knoxville : The University of Tennessee Medical Center

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Knoxville : Center for Biomedical Research

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Memphis :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Nashville : Tennessee Oncology

A clinical research study of MORAb-066

Nashville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Nashville :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Nashville : Sarah Cannon Research Institute

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Nashville :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Nashville :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Nashville : Sarah Cannon Cancer Center

A clinical trial seeking patients for a research study of LY2875358 and Ramucirumab

Nashville : Tennessee Oncology PLLC

A clinical trial seeking patients for a research study of LY2875358 and Ramucirumab

Nashville : Tennessee Oncology Updated

A clinical trial to evaluate treatments using MMB, Capecitabine and Oxaliplatin for patients with Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma

Nashville : Vanderbilt-Ingram Cancer Center

A clinical trial to evaluate treatments using panitumumab, irinotecan hydrochloride, fluorouracil and leucovorin calcium for patients

Nashville : Tennessee Oncology PLLC

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Nashville : Vanderbilt University Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Nashville : Vanderbilt-Ingram Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Texas

Amarillo : Texas Oncology, P.A.

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Arlington : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Arlington : Texas Health Physicians Group

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Arlington :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Beaumont : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Beaumont :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Bedford : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bedford :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Dallas : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Dallas : Baylor University Medical Center at Dallas

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Dallas :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Dallas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Dallas : Texas Oncology

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Dallas : UT Southwestern Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Dallas : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dallas : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Dallas :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Denton :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

El Paso :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Fort Worth :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Fort Worth : Center for Cancer and Blood Disorders

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Fort Worth :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Galveston : University of Texas Medical Branch

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Abraxane for the treatment of Colorectal Cancer or Cancer of Gastrointestinal Tract

Houston : Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Houston :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Houston : MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Houston : UT MD Anderson Cancer Center (Site 005)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Everolimus and LDE 225 for patients with Esophageal Cancer

Houston : University of Texas/MD Anderson Cancer Center MD Anderson 2

A Phase 1 clinical study for patients using LGK974

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Gastrointestinal Cancer

Houston : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Houston : Westchase Clinical Associates/Westchase Oncology Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Houston : M.D. Anderson Cancer Center

Patients are needed to participate in a clinical research study of selinexor to evaluate Prostate Cancer

Longview : Texas Oncology, P.A./Longview Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lubbock : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Plano :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Round Rock :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

San Antonio : Cancer Therapy and Research Center (CTRC), The University of Texas Health Science Center at San Antonio

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

San Antonio : South Texas Accelerated Research Therapeutics

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

San Antonio :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

San Antonio : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

San Antonio : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

San Antonio :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Tyler :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Tyler : Texas Oncology P.A. - Tyler

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Waco :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Utah

Ogden :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Salt Lake City : Huntsman Cancer Center

Patients are needed to participate in a clinical research study of Nab-Paclitaxel, Gemcitabine and Indoximod to evaluate Metastatic Pancreatic Adenocarcinoma or Metastatic Pancreatic Cancer

Salt Lake City :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

St. Lake City :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Virginia

Fairfax : Virginia Cancer Specialists, PC Updated

A clinical trial to evaluate treatments using MMB, Capecitabine and Oxaliplatin for patients with Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma

Newport News :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Richmond : Virginia Commonwealth University

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Richmond : Virginia Commonwealth University

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Roanoke :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Roanoke :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Washington

Bellingham : PeaceHealth Saint Joseph Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Everett : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Poulsbo : Harrison Health Partners Hematology and Oncology - Poulsbo

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Seattle : Swedish Health Services

A clinical study for patients with Lung Cancer, NSCLC or Lung Adenocarcinoma

Seattle : Virginia Mason Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Seattle : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seattle : Swedish Cancer Institute (Site 211)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seattle : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Seattle : Virginia Mason Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seattle : Seattle Cancer Care Alliance

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seattle : Virginia Mason Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Seattle :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Spokane Valley : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tacoma : Northwest Medical Specialties Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Tacoma : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vancouver : Northwest Cancer Specialists, PC

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

West Virginia

Huntington : Saint Mary's Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Morgantown : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wisconsin

Green Bay : Saint Vincent Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Green Bay : Saint Mary's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Green Bay : Green Bay Oncology at Saint Vincent Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Madison : University of Wisconsin Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer, Adenocarcinoma or Pancreatic Neoplasms

Madison : University of Wisconsin

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madison :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Manitowoc : Holy Family Memorial Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Marshfield : Marshfield Clinic

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Marshfield : Saint Joseph's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Milwaukee : Medical College of Wisconsin

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Oconto Falls : Green Bay Oncology - Oconto Falls

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Sheboygan : Saint Nicholas Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Stevens Point : Saint Michael's Hospital Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Stevens Point : Marshfield Clinic at Saint Michael's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Sturgeon Bay : Green Bay Oncology - Sturgeon Bay

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Weston : Marshfield Clinic - Weston Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Weston : Diagnostic and Treatment Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Argentina

Ciudad Autonoma de Buenos Aires : Instituto de Oncologia Angel H. Roffo

A clinical research study of CIGB300 for the treatment of Squamous Cell Carcinoma of the Cervix or Adenocarcinoma of the Cervix

Australia

Australian Capital Territory :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Bentleigh East : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Bentleigh East : Monash Medical Centre Moorabbin Campus

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Douglas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Elizabeth Vale : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Fitzroy : St Vincent's Hospital Melbourne (Site997)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Frankston : Peninsula & South Eastern Haematology Group (Site 994)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Garran : The Canberra Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Heidelberg : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Heidelberg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Herston : Royal Brisbane & Women's Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Kogarah : The St George Hospital, Cancer Care Center (Site 403)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Kurralta Park : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Kurralta Park : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Malvern : Cabrini Hospital Malvern

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New South Wales :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Randwick : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ringwood East : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

South Brisbane : Icon Cancer Care South Brisbane

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

St Leonards : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

St Leonards : Northern Cancer Institute, St Leonards

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Subiaco : St John of God Hospital Subiaco

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sydney : Prince of Wales Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tweed Heads : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Austria

Graz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Graz : Medizinische Universität Graz

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Innsbruck : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Innsbruck : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Innsbruck : Universitätsklinikum Innsbruck

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Krems : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kufstein : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Linz :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Linz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Linz : A.ö. Krankenhaus der Elisabethinen

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Linz : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Linz : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Salsburg :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Salzburg : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Salzburg : St.-Johanns-Spital, Universitatsklinik fur Pneumologie/Lungenheilkunde (Site 627)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Salzburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Salzburg : Salzburger Landeskliniken

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Vienna : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vienna : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wels : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Wels : Klinikum Wels-Grieskirchen GmbH

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Wels : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wien : SMZ Baumgartner Hohe Otto Wagner Spital, Onkologische Ambulanz+Tagesklinik (Site 612)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Wien : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Wien : Kaiser Franz Josef Spital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Wien : Medizinische Universität Wien

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Belgium

Brussels : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Brussels : Hôpital Erasme

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Brussels : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Brussels (Anderlecht) : Research Site

Patients are needed to participate in a clinical research study of Olaparib and Placebo to evaluate Germline BRCA1/2 Mutations and or Metastatic Adenocarcinoma of the Pancreas

Bruxelles : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bruxelles : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Charleroi : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Charleroi : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edegem : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Edegem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edegem : UZ Antwerpen

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gent : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Gent : UZ Gent

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Haine St. Paul : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Jette : AZ VUB

A Phase 2 clinical study for patients with Lung Neoplasms, Non-Small Cell Lung Cancer or Adenocarcinoma, Bronchiolo-Alveolar

Leuven : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Leuven : UZ Leuven

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Leuven : Research Site

Patients are needed to participate in a clinical research study of Olaparib and Placebo to evaluate Germline BRCA1/2 Mutations and or Metastatic Adenocarcinoma of the Pancreas

Liege : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Liège : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Liège : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Roeselare : H.-Hartziekenhuis Roeselare-Menen vzw (Site 617)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Yvoir : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bosnia and Herzegovina

Banja Luka : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Banja Luka : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sarajevo : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sarajevo : Synta Pharmaceuticals Investigative Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tuzla : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zenica : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Brazil

Belo Horizonte : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pelotas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Santo Andre : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sao Paulo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sao Paulo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

São Paulo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bulgaria

Plovdiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Shumen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Varna : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Canada

Calgary : Tom Baker Cancer Centre

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Edmonton : Cross Cancer Institute

A clinical research study of Irinotecan-Capecitabine-Oxaliplatin for the treatment of Gastrointestinal Neoplasm or Gastric Adenocarcinoma

Edmonton : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Greenfield Park : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Laval : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montreal : Montreal General Hospital

A clinical research study of Androgen suppression plus radiation therapy for the treatment of Adenocarcinoma of the Prostate

Montreal : Jewish General Hospital

A clinical research study of Androgen suppression plus radiation therapy for the treatment of Adenocarcinoma of the Prostate

Montreal : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montreal : Jewish General Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Montreal : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Oshawa :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Ottawa : The Ottawa Hospital Cancer Centre (Site 131)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Toronto : Princess Margaret Hospital

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Toronto : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Toronto : Princess Margaret Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chile

Santiago :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Santiago : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Vitacura :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

China

Beijing : Cancer Hospital, Chinese Academy of Medical Science

A clinical research study of Icotinib and Placebo for the treatment of EGFR Positive Non-small Cell Lung Cancer or Adenocarcinoma

Beijing : Chinese People's Liberation Army (PLA) General Hospital

A clinical trial seeking patients for a research study for the treatment of EGFR Positive Non-small Cell Lung Cancer or Adenocarcinoma

Beijing : Cancer Insititute and Hospital,Chinese Academy of Medical Sciences

A clinical trial seeking patients for a research study for the treatment of Liver Cancer or Pancreatic Adenocarcinoma

Beijing : Cancer Hospital, Chinese Academy of Medical Sciences

A Phase 2 clinical study for patients with Adenocarcinoma of the Gastroesophageal Junction or Esophageal Carcinoma

Beijing : Peking Unicersity Cancer Hospital

A Phase 3 clinical study for patients with Advanced Gastric Carcinoma

Beijing : Department of GI Oncology, Peking University, School of Oncology

Patients are needed to participate in a clinical research study evaluating Paclitaxel, capecitabine and cisplatin for the treatment of Advanced Gastric Cancer

Beijing : Beijing Cancer Hospital

Patients are needed to participate in a clinical research study of SOX sequential S-1 to evaluate Biliary Tract Cancer, Periampullary Adenocarcinoma or Pancreatic Cancer

Changchun : The First Bethune Hospital of Jilin Univercity

A Phase 3 clinical study for patients with NSCLC

Chengdu : Sichuan Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Guangzhou : Sun Yat-sen University Cancer Center

A clinical trial to evaluate treatments using S-1, Oxaliplatin and Cisplatin for patients with Gastric Cancer

Harbin : Harbin Medical Univercity Cancer Hospital

A Phase 3 clinical study for patients with NSCLC

Shenyang : The First Hospital of China Medical University

A Phase 3 clinical study for patients with NSCLC

Shijiazhuang : Hebei Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Xian : Xijing Hospital

A Phase 3 clinical study for patients with NSCLC

Zhengzhou : Henan Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Croatia

Zagreb : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Czech Republic

Horovice : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Hradec Kralove : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Hradec Kralove : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Hradec Kralove : Fakultni nemocnice Hradec Kralove

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Liberec : Krajska nemocnice Liberec, a.s.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Olomouc : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Olomouc : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olomouc : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ostrava : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Praha 2 : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Praha 2 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Usti nad Labem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Zlin : Krajska nemocnice T. Bati a.s.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Denmark

Aalborg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Copenhagen : Rigshospitalet

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Copenhagen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

DK 2730 Herlev : Herlev Hospital (Site 614)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Herlev : Herlev Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Odense : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Odense C : Odense University Hospital (Site 615)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Finland

Helsinki : Helsingin Yliopistollinen Keskussairaala

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Kuopio : Kuopio University Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Oulu : Oulu Univerity Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Tampere : Tampereen yliopistollinen sairaala

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tampere : University of Tampere

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Turku : Turun Yliopistollinen Keskussairaala

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Turku : Department of Oncology and Radiotherapy, turku University Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Vaasa : Vaasa Distric Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

France

Angers : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Angers cedex 12 : CHU Angers

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Bayonne : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bordeaux : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Clermont Ferrand Cedex 1 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Creteil : Hopital Henri Mondor

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of Prostate

Creteil : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Créteil : Hopital Henri Mondor

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Dijon cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gap : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Grenoble : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Le Mans : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lille : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Lille : CHRU Lille

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lille : Centre Oscar Lambret

Patients are needed to participate in a clinical research study of Aflibercept-FOLFIRI to evaluate Metastatic Colorectal Cancer

Lyon Cedex 06 : Groupement Hospitalier Edouard Herriot

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lyon Cedex 08 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lyon cedex 8 : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Marseille cedex 5 : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Marseille cedex 5 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montpellier Cedex 5 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nice cedex 2 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Paris : Hôpital Européen Georges Pompidou

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Paris : Groupe Hospitalier Pitie Salpetriere

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Périgueux cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Poitiers : CHRU de Poitiers La Miletrie

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Reims : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Rennes : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Saint Herblain : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Saint Priest en Jarez : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Strasbourg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Strasbourg : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Villefranche-sur-Saone : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Villejuif : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Villejuif : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Villejuif : Institut Gustave Roussy

Patients are needed to participate in a clinical research study of OTX015

Germany

Bad Nauheim : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Berlin : Evangelische Lungenklinik Berlin

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Berlin : Evangelische Lungenklinik Berlin (Site 588)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Berlin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Berlin : Charité - Universitätsmedizin Berlin

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Berlin : Charité - Universitätsmedizin Berlin

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Cologne : University of Cologne / LCGC

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Cologne : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dresden : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Essen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Frankfurt a.M. : Universitätsklinikum Frankfurt - Medizinische Klinik II

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Frankfurt am Main : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Friedrichshafen : Praxis für Innere Medizin Droettle Helmut

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gauting : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Großhansdorf : LungenClinic Großhansdorf

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Grosshansdorf : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Halle : Krankenhaus Martha Marie Halle (Site 572)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hamburg : Research Site

A clinical trial to evaluate treatments using AMG 211 for patients with Gastrointestinal Cancer, Adenocarcinoma

Hamburg : Universitätsklinikum Hamburg Eppendorf

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Hamburg : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Heidelberg : Thoraxklinik Heidelberg

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Heidelberg : NCT-Med. Onkologie

A clinical trial seeking patients for a research study for the treatment of Metastatic Esophagogastric Adenocarcinoma

Heidelberg : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Heidelberg : Thoraxklinik-Heidelberg gGmbH, Innere Medizin - Onkologie (Site 586)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hemer : Lungenklinik Hemer, Zentrum fur Pneumologie und Thoraxchirurgie (Site 620)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hessen : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kassel : Klinikum Kassel GmbH, Klinik fur Onkologie und Hamatologie (Site 573)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Köln : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Leipzig :

A clinical research study for the treatment of Non-Small Cell Lung Cancer

Leipzig : Prof. Dr. F. Lordick

A clinical research study of catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel and Fluorouracil, leucovorin, oxaliplatin, docetaxel for the treatment of Gastric Adenocarcinoma With Peritoneal Carcinomatosis, Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis or Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis

Leipzig : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Leipzig : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Leubeck : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Magdeburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mainz : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Mainz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mainz : Universitätsmedizin der Johannes Gutenberg-Universität Mainz

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Mainz : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Mannheim : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Muenster : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Munchen : LMU - Klinikum der Universitat Munchen, Campus Innenstadt, Medizinische Klinik V, Pneumologie (Site 609)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

München : Research Site

A clinical trial to evaluate treatments using AMG 211 for patients with Gastrointestinal Cancer, Adenocarcinoma

München : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

München : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

München : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

München : Klinikum Neuperlach

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Munich : University of Munich

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Offenbach : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Schweinfurt : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Würzburg : Universitätsklinikum Würzburg/Comprehensive Cancer Center Mainfranken

A clinical trial seeking patients for a research study for the treatment of Ductal Adenocarcinoma of the Pancreas

Würzburg : Universitätsklinikum Würzburg

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Greece

Athens : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Heraklion - Crete : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Heraklion - Crete : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ioannina : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Larissa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nea Kifissia, Athens : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Patra : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Piraeus : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Thessaloniki : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Thessaloniki : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Hong Kong

Hong Kong : Queen Mary Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Hong Kong : Queen Mary Hospital, Department of Clinical Oncology (Site 986)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hong Kong : Queen Mary Hospital, Division of Respiratory and Critical Care Medicine (Site 973)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Kowloon : Queen Elizabeth Hospital, Department of Clinical Oncology (Site 987)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Pok Fu Lam : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Sha Tin : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Hungary

Budapest : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Budapest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Budapest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Budapest : Uzsoki Utcai Kórház

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Budapest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Budapest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Debrecen : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Debrecen : Debreceni Egyetem Orvos-és Egészségtudományi Centrum

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Deszk : Synta Pharmaceuticals Investigative Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Gyor : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kaposvar : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Nyiregyhaza : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Szeged : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Szekesfehervar : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Szolnok : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Szolnok : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ireland

Dublin : Saint Vincent's University Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Israel

Haifa : Rambam Healthcare Campus

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Haifa : Rambam medical Center

A clinical trial to evaluate treatments using Capecitabine (Xeloda) for patients with Adenocarcinoma Clear Cell

Jerusalem : Hadassah Hebrew University Hospital (Sharett Institute of Oncology)

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Tel Aviv : Tel Aviv Sourasky Medical Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Italy

Ancona : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Ancona : Az Osp University Ospedali Riuniti umberto I GM Lancisi Gsalesi

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Aviano PN : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bologna : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Brescia : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Brescia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Catania : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cremona : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Firenze : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Firenze : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Firenze : Azienda Ospedaliera Universitaria Careggi

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Genova : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Meldola : Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Meldola (FC) : U.O. Oncologia Medica, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)_IRCCS (Site 575)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Milano : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Milano : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Milano : Dipartimento di Oncologia Medica Ospedale San Raffaele, Istituto di Ricovero e Cura a Carattere Scientifico (Site 578)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Milano : Divisione Oncologia Toracica, Istituto Europeo di Oncologia, Istituto di Ricovero e Cura a Carattere Scientifico (Site608)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Milano : Ospedale San Raffaele S.r.l.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Napoli : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Napoli : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Napoli :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Parma : Struttura Complessa Oncologia Medica Azienda Ospedaliero-Universitaria di Parma (Site 607)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Pisa : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Pisa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pisa : Azienda Ospedaliero Universitaria Pisana

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Reggio Emilia : Arcispedale Santa Maria Nuova

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Roma : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Roma : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Roma : Istituto Nazionale Tumori Regina Elena

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rozzano : Istituto Clinico Humanitas

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rozzano MI : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

San Giovanni Rotondo : Ospedale Casa Sollievo Della Sofferenza IRCCS

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Terni : Azienda Ospedaliera S Maria Di Terni

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Torino : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Udine : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Verona : Azienda Ospedaliera Universitaria Integrata Di Verona

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Japan

Chuo-ku : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Kobe : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Nagoya : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Natori : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Osaka, Osaka : 1199.90.81006 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating Nintedanib and Docetaxel for the treatment of Carcinoma, Non-Small-Cell Lung

Osaka, Osakasayama : 1199.90.81007 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating Nintedanib and Docetaxel for the treatment of Carcinoma, Non-Small-Cell Lung

Osaka, Takatsuki : 1199.90.81005 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating Nintedanib and Docetaxel for the treatment of Carcinoma, Non-Small-Cell Lung

Osaka-Sayama : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Tokyo, Chuo : 1199.90.81002 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating Nintedanib and Docetaxel for the treatment of Carcinoma, Non-Small-Cell Lung

Korea, Republic of

Busan : Pusan National University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Busan : Gosin University Gospel Hospital

Patients are needed to participate in a clinical research study of Erlotinib and Silybin-phytosome to evaluate Carcinoma, Non-Small-Cell Lung

Daegu : Kyungpook National University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Daegu : Kyungpook National University Medical Center

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Dong-gu : Ulsan University Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Gangnam-gu : Samsung Medical Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Goyang-si : National Cancer Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Goyang-si : Inje University Ilsan Paik Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Goyang-si : National Cancer Center (Site 916)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Goyang-si : National Cancer Center

Patients are needed to participate in a clinical research study evaluating Gefitinib, Placebo and Pemetrexed plusCIsplatin for the treatment of Non Small Cell Lung Cancer or Adenocarcinoma

Goyang-si, Gyeonggi-do : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Hwasun : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Hwasun-gun :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Incheon : Inha University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Jongno-gu : Seoul National University Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Namdong-Gu : Gachon University Gil Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Seongnam-si :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Seoul : Severance Hospital, Yonsei University Health System

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Korea University Anam Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : The Catholic University of Korea, Seoul St.Mary's Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Samsung Medical Center

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seoul : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seoul : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seoul : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seoul : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seoul : Seoul National University Hospital (Site 915)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Asan Medical Center (Site 917)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Severance Hospital, Yonsei University Health System (Site 913)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : The Catholic University of Korea Seoul St. Mary's Hospital (Site 938)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Songpa-gu : Asan Medical Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Malaysia

Kuala Lumpur : University Malaya Medical Centre

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Negeri Sembilan : Nilai Medical Centre

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Mexico

Cuernavaca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Distrito Federal : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mexico : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Toluca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Netherlands

Amsterdam : VU Medical Center (Site 948)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Amsterdam : Academic Medical Center

Patients are needed to participate in a clinical research study to evaluate Barrett'S-associated Dysplasia or Intramucosal Adenocarcinoma

Assen : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Groningen : Research Site

A clinical trial to evaluate treatments using AMG 211 for patients with Gastrointestinal Cancer, Adenocarcinoma

Groningen : University Medical Center Groningen (Site 581)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Harderwijk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Maastricht : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Masstricht : Maastricht UMC+ (Site 580)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Rotterdam : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Utrecht : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zutphen : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zwolle : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Philippines

San Juan : Cardinal Santos Medical Center

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Poland

Bialystok : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Bialystok : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Elblag : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Elblag : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gdansk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Konin : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Konin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Krakow : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lodz : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Lodz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olsztyn : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Poznan : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prabuty : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Szczecin : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Warsaw : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Warszawa : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Warszawa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Portugal

Aveiro : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Guimaraes : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lisbao : Hospital Da Luz

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lisboa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lisboa : Centro Hospitalar de Lisboa Central

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Porto : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Porto : Centro Hospitalar de Sao Joao EPE

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Santa Maria da Feira : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Vila Real : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Romania

Alba Iulia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Baia Mare : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Brasov : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj-Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj-Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj-Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Craiova : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Iasi : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lasi : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Timisoara : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Russian Federation

Chelyabinsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ivanovo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kazan : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Krasnodar : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Krasnodar : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Moscow : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Moscow : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Saint-Petersburg : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Saint-Petersburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Samara : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Vladimir : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Serbia

Belgrade :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Knez Selo :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Kragujevac : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nis : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sremska Kamenica :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Sremska Kamenica : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Singapore

Singapore : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Singapore : National Cancer Centre Singapore, Depart of Medical Oncology (Site 989)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Singapore : OncoCare Cancer Centre (Site 988)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Slovakia

Bardejov : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bratislava : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Poprad : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Trencin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Slovenia

Golnik : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ljubljana : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

South Africa

Cape Town : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Groenkloof : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Johannesburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kraaifontein : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pretoria : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Spain

A Coruna : Hospital Teresa Herrera (Site 554)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

A Coruña : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Alicante : Hospital General Universitario de Alicante (Site 591)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Badalona : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Barcelona :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Barcelona : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Barcelona : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Barcelona : Hospital Universitari de la Vall d'Hebron Servicio de Oncologia Medica (Site 503)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Barcelona : Hospital Universitario Quiron Dexeus, Servicio de Oncologia Medica (Site 590)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Barcelona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Barcelona : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Barcelona : Hospital Universitario Vall d'Hebron

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Barcelona : Hospital Clinic de Barcelona

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Barcelona : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona : ACROSS

Patients are needed to participate in a clinical research study evaluating bevacizumab for the treatment of Rectal Neoplasms or Locally Advanced Rectal Adenocarcinoma

Córdoba : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Elche : Hospital General Universitario de Elche

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Fuenlabrada : Hospital Universitario de Fuenlabrada

Patients are needed to participate in a clinical research study evaluating Arm A chemotherapy and arm B chemotherapy for the treatment of Adenocarcinoma of Colon, Adenocarcinoma of Rectum or Metastatic Disease

Instituto Catalan de Oncologia de Hospitalet (ICO) : Instituto Catalan de Oncologia de Hospitalet (ICO)

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

La Coruña : Centro Oncológico de Galícia

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

La Coruña : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

L'Hospitalet de Llobregat : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

L'Hospitalet de Llobregat, Barcelona : Institut Català d'Oncologia

A Phase 1 clinical study for patients with Locally Advanced Pancreatic Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma

Madrid :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Madrid :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Madrid : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Madrid : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Madrid : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Madrid : Hospital Universitario La Paz (Site 582)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Madrid : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Madrid : Centro Integral Oncológico Clara Campal

A Phase 1 clinical study for patients with Locally Advanced Pancreatic Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma

Madrid : Centro Integral Oncologico Clara Campal

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Universitario 12 de Octubre

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Universitario Ramon y Cajal

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital General Universitario Gregorio Marañón

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Madrid Norte Sanchinarro

Patients are needed to participate in a clinical research study evaluating Arm A chemotherapy and arm B chemotherapy for the treatment of Adenocarcinoma of Colon, Adenocarcinoma of Rectum or Metastatic Disease

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Hospital Universitario Madrid Sanchinarro

Patients are needed to participate in a clinical research study of lurbinectedin (PM01183) and Doxorubicin to evaluate Endometrial Adenocarcinomas, Neuroendocrine Tumors or Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy)

Madrid : Ramon Y Cajal

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Madrid : Hospital 12 de Octubre

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Madrid : Research Site

Patients are needed to participate in a clinical research study of Olaparib and Placebo to evaluate Germline BRCA1/2 Mutations and or Metastatic Adenocarcinoma of the Pancreas

Malaga : Hospital Regional Universitario de Malaga

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Malaga : Hospital Universitario Carlos Haya

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Málaga : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Mataró : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Oviedo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pamplona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pamplona : Complejo Hospitalario de Navarra

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

San Sebastian : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Santander : Hospital Universitario Marques de Valdecilla

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Santander : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Santander : Hospital Universitario Santander

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Santiago de Compostela : Hospital Clinico Universitario de Santiago

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sevilla : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Sevilla : Hospital Virgen del Rocio

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seville :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Terrassa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Valencia : Hospital Clinico Universitario de Valencia (Site 589)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Valencia : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sweden

Eskilstuna : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Goteborg : Sahlgrenska Universitetssjukhuset (Site 758)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Linkoping :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Stockholm : Dept. of Oncology-Pathology, Karolinska University Hospital, Solna

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Stockholm : Dept. of Clinical Science, Intervention and Technology, Div. of surgery, Karolinska University Hospital, Huddinge

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Stockholm : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Uppsala :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Switzerland

Bellinzona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bern : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Chur : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Zurich : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Taiwan

Taichung : China Medical University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Taipei : Updated

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Taipei : Mackay Memorial Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Taipei City : National Taiwan University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Thailand

Bangkok : Chulalongkorn University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Bangkok : Siriraj Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Pathumthani : Thammasat University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Turkey

Ankara : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gaziantep : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Istanbul : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Izmir : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ukraine

Dnipropetrovsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kharkiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kherson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kyiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lutsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lviv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mariupol : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sumy : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Uzhgorod : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

United Kingdom

Aberdeen :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Aberdeen : Aberdeen Royal Infirmary

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Bangor :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Belfast : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bournemouth : Royal Bournemouth Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Bradford : Bradford Royal Infirmary

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Bristol : Bristol Haematology and Oncology Centre

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Cambridge : Addenbrookes Hospital

Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)

Cambridge : Addenbrooke's Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Cardiff : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cardiff : Velindre Cancer Center at Velindre Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Carlisle : Cumberland Infirmary

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Doncaster : Doncaster Royal Infirmary

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Edinburgh : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Edinburgh : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edinburgh : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Guildford : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Guildford : St. Luke's Cancer Centre at Royal Surrey County Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Huddersfield, West Yorks : Huddersfield Royal Infirmary

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Leeds : Leeds Cancer Centre at St. James's University Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Leicester : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Leicester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Leicester : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lincoln : Lincoln County Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Liverpool : Research Site

Patients are needed to participate in a clinical research study of Olaparib and Placebo to evaluate Germline BRCA1/2 Mutations and or Metastatic Adenocarcinoma of the Pancreas

Liverpool : Aintree University Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

London :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

London :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

London : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : UCLH (University College London Hospitals)

Patients are needed to participate in a clinical research study of lurbinectedin (PM01183) and Doxorubicin to evaluate Endometrial Adenocarcinomas, Neuroendocrine Tumors or Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy)

London : Research Site

Patients are needed to participate in a clinical research study of Olaparib and Placebo to evaluate Germline BRCA1/2 Mutations and or Metastatic Adenocarcinoma of the Pancreas

London :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

London : St. George's Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

London : St. Mary's Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

London : Saint Bartholomew's Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Maidstone : Mid Kent Oncology Centre at Maidstone Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Manchester :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Manchester :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Manchester : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Manchester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Manchester : Research Site

A Phase 1/Phase 2 clinical study for patients with Advanced Solid Malignancies, ATM Deficient NSCLC Adenocarcinoma, High Grade Serous Ovarian Cancer

Manchester :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Manchester : Christie Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Merseyside : Clatterbridge Centre for Oncology

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Newcastle Upon Tyne : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Newcastle-Upon-Tyne : Northern Centre for Cancer Treatment at Newcastle General Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Northwood : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Northwood : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nottingham : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nottingham : Nottingham Univeristy Hospitals NHS Trust

Patients are needed to participate in a clinical research study evaluating Iron isomaltoside 1000 for the treatment of Anemia, Esophageal Cancer or Gastric Cancer

Plymouth :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Plymouth : Derriford Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Poole Dorset : Dorset Cancer Centre

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Reading : Berkshire Cancer Centre at Royal Berkshire Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Rochdale : Rochdale Infirmary

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Salisbury : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Salisbury : Salisbury District Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Sheffield : Weston Park Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Shrewsbury : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Slough, Berkshire : Wexham Park Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Southampton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Southampton : Southampton General Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Surrey : Research Site

Patients are needed to participate in a clinical research study of Olaparib and Placebo to evaluate Germline BRCA1/2 Mutations and or Metastatic Adenocarcinoma of the Pancreas

Sutton : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Sutton : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sutton : Research Site

A Phase 1/Phase 2 clinical study for patients with Advanced Solid Malignancies, ATM Deficient NSCLC Adenocarcinoma, High Grade Serous Ovarian Cancer

Sutton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sutton : Royal Marsden - Surrey

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Swindon : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Truro : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

 

Kidney & Urology Foundation of America | 152 Madison Ave, Suite 201 | New York, NY 10016 | 1.800.633.6628
©

About Us | Patient Resources | Professional Resources | Support Us | News & Recent Events | Brochures
Corporate Sponsors | Contact Us | Terms of Use | Privacy Policy

Website Last Modified: October 28, 2010
Donate Today Donate Your Car Join KUFA Now